Helius Medical Technologies will showcase its innovative new Portable Neuromodulation Stimulator (PoNS) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 in Chicago. Visitors to booth 512 will see the PoNS therapy device and learn more about how it can improve gait deficiency in people with multiple sclerosis (MS).
PoNS works by delivering electrical impulses through nerve fibers on the tongue, stimulating the flow of millions of neural impulses to the brain structures that control gait. This creates a cascade of activity in the brain that – when combined with an exercise regimen supervised by a physical therapist – produces a neuromodulatory and neuroplastic effect that can have a significant impact on the independence and personal productivity of people with MS.
“The ACRM is committed to helping people live their fullest lives by improving, expanding and regaining mobility, and we’re excited to exhibit at the Conference because we share the same goals,” said Antonella Favit-Van Pelt, MD, PhD, Helius’ Chief Medical Officer. “PoNS addresses a complication that’s very top-of-mind for people with MS: 70% of them report having difficulty walking, and of that group 70% identify gait deficit as the most challenging aspect of their disease.”
In addition to seeing the PoNS device in person, booth visitors can speak with key Helius team members, who can answer questions about PoNS and the accompanying PoNS Therapy regimen that maximizes its effectiveness. Physical therapists also will be able to sign up for free, online PoNS Therapy training.
“Rehabilitation professionals who work with people with MS, or are interested in the relationship between neuromodulation and gait, are invited to visit us at booth 512,” said Favit-Van Pelt. “But this is more than just a chance to see the device and talk, it’s an opportunity to take action: By signing up for training physical therapists are making themselves even more invaluable to their patients with MS.”
[Source(s): Helius Medical Technologies Inc, GlobeNewswire]
